[1] DIAKOS CI,CHARLES KA,MCMILLAN DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):e493-e503.
[2] SUZUKI T,SHIMADA H,NANAMI T,et al.Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer[J].Surg Today,2016,46(12):1394-1401.
[3] MIYAZAKI T,NAGAYASU T.Editorial on "Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals"[J].J Thorac Dis,2019,11(Suppl 9):S1241-S1244.
[4] WOLBERG AS.Fibrinogen and factor XIII:newly recognized roles in venous thrombus formation and composition[J].Curr Opin Hematol,2018,25(5):358-364.
[5] DOLLOFF NG,SHULBY SS,NELSON AV,et al.Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor[J].Oncogene,2005,24(45):6848-6854.
[6] SEEBACHER V,POLTERAUER S,GRIMM C,et al.The prognostic value of plasma fibrinogen levels in patients with endometrial cancer:a multi-centre trial[J].Br J Cancer,2010,102(6):952-956.
[7] CAI W,KONG W,DONG B,et al.Pretreatment serum prealbumin as an independent prognostic indicator in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors as first-line target therapy[J].Clin Genitourin Cancer,2017,15(3):e437-e446.
[8] FAN L,CHI C,GUO S,et al.Serum pre-albumin predicts the clinical outcome in metastatic castration-resistant prostate cancer patients treated with abiraterone[J].J Cancer,2017,8(17):3448-3455.
[9] 王夺,梁夏宜,刘军杰,等.术前血清前白蛋白水平与甲胎蛋白阴性肝细胞癌患者预后的关系[J].中国癌症防治杂志,2019,11(04):323-326.
WANG D,LIANG XY,LIU JJ,et al.Correlation between serum prealbumin and prognosis in patients with alpha-fetoproteinnegative hepatocellular carcinoma[J].Chinese Journal of Oncology Prevention and Treatment,2019,11(04):323-326.
[10] 王文飞,苏航.血清白蛋白、前白蛋白与霍奇金淋巴瘤患者近期疗效关系的临床观察[J].临床肿瘤学杂志,2018,23(07):621-625.
WANG WF,SU H.Clinical significance of serum albumin and prealbumin in the short-term efficacy of hodgkin lymphoma[J].Chinese Clinical Oncology,2018,23(07):621-625.
[11] 邓淑娇,雍文穆.血浆纤维蛋白原和血清白蛋白水平评分在非小细胞肺癌患者预后评估中的作用[J].国际呼吸杂志,2019,39(04):263-268.
DENG SJ,YONG WM.The role of plasma fibrinogen and serum albumin levels in the prognosis evaluation of patients with non-small cell lung cancer[J].International Journal of Respiration,2019,39(04):263-268.
[12] TERZIC J,GRIVENNIKOV S,KARIN E,et al.Inflammation and colon cancer[J].Gastroenterology,2010,138(6):2101-2114.
[13] LEE JL,OH ES,LEE RW,et al.Serum albumin and prealbumin in calorically restricted,nondiseased individuals:A systematic review[J].Am J Med,2015,128(9):1021-1023.
[14] RIVADENEIRA DE,GROBMYER SR,NAAMA HA,et al.Malnutrition-induced macrophage apoptosis[J].Surgery,2001,129(5):617-625.
[15] REYNOLDS JV,REDMOND HP,UENO N,et al.Impairment of macrophage activation and granuloma formation by protein deprivation in mice[J].Cell Immunol,1992,139(2):493-504.
[16] YAMASHITA S,KOHJIMOTO Y,IGUCHI T,et al.Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy[J].BMC Urol,2016,16:13.
[17] SUN DW,AN L,LV GY.Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers:an updated meta-analysis[J].World J Surg Oncol,2020,18(1):9.
[18] LI SQ,JIANG YH,LIN J,et al.Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals[J].Cancer Med,2018,7(4):1221-1231.
[19] HAMANAKA K,MIURA K,KOYAMA T,et al.The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer:a simple,economical,and effective biomarker[J].J Thorac Dis,2019,11(Suppl 3):S241-S244.
[20] 李然天,孙紫千,王红兵.纤维蛋白原与前白蛋白比值对中晚期非小细胞肺癌预后作用的研究[J].临床肿瘤学杂志,2019,24(03):237-241.
LI RT,SU ZQ,WANG HB.Prognostic value of fibrinogen-to-prealbumin ratio in patients with advanced non-small cell lung cancer[J].Chinese Clinical Oncology,2019,24(03):237-241.
[21] WANG Y,LI J,CHANG S,et al.Low albumin to fibrinogen ratio predicts poor overall survival in esophageal small cell carcinoma patients:A retrospective study[J].Cancer Manag Res,2020,12:2675-2683.
[22] FENG JF,WANG L,JIANG YH,et al.A novel prognostic index in patients with resectable esophageal squamous cell carcinoma:Fibrinogen/prealbumin ratio[J].Rev Invest Clin,2020,72(1):46-54.
[23] 张俊斌,王浩浩,王伟斌,等.前白蛋白/纤维蛋白原比值与胃癌临床病理特征的关系[J].世界华人消化杂志,2019,27(18):1133-1141.
ZHANG JB,WANG HH,WANG WB,et al.Association of prealbumin/fibrinogen ratio with clinicopathologic characteristics of gastric cancer[J].World Chinese Journal of Digestology,2019,27(18):1133-1141.
[24] FENG LW,LI J,LIANG LF,et al.A predictive scoring system based on inflammatory and tumor markers for gastric cancer patients undergoing curative resection[J].Cancer Manag Res,2020,12:3937-3948.
[25] TANG S,LIN L,CHENG J,et al.The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer[J].BMC Cancer,2020,20(1):382.
[26] ZHANG J,RUAN J,WANG W,et al.Prognostic value of the combination of CEA and fibrinogen/albumin ratio in resectable gastric cancer[J].Cancer Manag Res,2020,12:2767-2775.
[27] ZHANG J,DING Y,WANG W,et al.Combining the fibrinogen/albumin ratio and systemic inflammation response index predicts survival in resectable gastric cancer[J].Gastroenterol Res Pract,2020,2020:3207345.
[28] YOU X,ZHOU Q,SONG J,et al.Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy[J].BMC Cancer,2019,19(1):931.
[29] LIU C,LI X.Stage-dependent changes in albumin,NLR,PLR,and AFR are correlated with shorter survival in patients with gastric cancer[J].Clin Lab,2019,65(9):1623-1633.
[30] ZHANG L,QIN S,LU L,et al.Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios in Hp-negative gastric cancer[J].Int J Biol Markers,2022,37(1):66-73.
[31] WANG YY,LIU ZZ,XU D,et al.Fibrinogen-albumin ratio index (FARI):A more promising inflammation-based prognostic marker for patients undergoing hepatectomy for colorectal liver metastases[J].Ann Surg Oncol,2019,26(11):3682-3692.
[32] SUN F,TAN YA,GAO QF,et al.Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer[J].J Clin Lab Anal,2019,33(1):e22635.
[33] ZHANG L,ZHANG J,WANG Y,et al.Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer[J].J Clin Lab Anal,2019,33(8):e22958.
[34] YING HQ,CHEN W,XIONG CF,et al.Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer[J].Cancer Cell Int,2022,22(1):137.
[35] XU Q,YAN Y,GU S,et al.A novel inflammation-based prognostic score:The fibrinogen/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma[J].J Immunol Res,2018,2018:4925498.
[36] 章蕾.纤维蛋白原与前白蛋白比值预测肝细胞癌预后的价值研究[D].南昌:南昌大学,2019.
ZHANG L.The value of Fibrinogen to pre-albumin ratio in predicting the prognosis of hepatocellular carcinoma[D].Nanchang:Nanchang University,2019.
[37] XU WY,ZHANG HH,XIONG JP,et al.Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients[J].World J Gastroenterol,2018,24(29):3281-3292.
[38] ZHENG Y,WU C,YAN H,et al.Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer:A prognostic nomogram study[J].Clin Chim Acta,2020,506:110-121.
[39] HUANG L,MO Z,ZHANG L,et al.Diagnostic value of albumin to fibrinogen ratio in cervical cancer[J].Int J Biol Markers,2020,35(2):66-73.
[40] YU W,YE Z,FANG X,et al.Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer[J].J Ovarian Res,2019,12(1):88.
[41] ZOU YX,QIAO J,ZHU HY,et al.Albumin-to-fibrinogen ratio as an independent prognostic parameter in untreated chronic lymphocytic leukemia:A retrospective study of 191 cases[J].Cancer Res Treat,2019,51(2):664-671.